MedPath
HSA Approval

MOCLOBEMIDE HEXAL TABLET 150mg

SIN13093P

MOCLOBEMIDE HEXAL TABLET 150mg

MOCLOBEMIDE HEXAL TABLET 150mg

April 21, 2005

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N06AG02

moclobemide

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Salutas Pharma GmbH

Active Ingredients

MOCLOBEMIDE

150mg

Moclobemide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOCLOBEMIDE HEXAL TABLET 150mg - HSA Approval | MedPath